✦ LIBER ✦

Adaptation of the cellscan technique for the SCM test in breast cancer

✍ Scribed by H. Rahmani; M. Deutsch; I. Ron; S. Gerbat; R. Tirosh; A. Weinreb; S. Chaitchik; S. Lalchuk

Book ID: 116167965
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 981 KB
Volume: 32
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(96)00181-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Letter to the editor: Comments on Adapta

Letter to the editor: Comments on Adaptation of the cellscan technique for the SCM test in breast cancer: Rahmani et al., Eur.J. Cancer, 32A, no. 10, pp. 1758–1765 1996

✍ S Birindelli; M.I Colnaghi; S Pilotti 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 246 KB

A flow system adaptation of the SCM test

A flow system adaptation of the SCM test for detection of lymphocyte response in patients with recurrent breast cancer

✍ S. Stewart; K.I. Pritchard; J.W. Meakin; G.B. Price 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 716 KB

An evaluation of the SCM test for the di

An evaluation of the SCM test for the diagnosis of cancer of the breast

✍ Chaitchik, S.; Deutsch, M.; Asher, O.; Krauss, G.; Lebovich, P.; Michlin, H.; We 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 532 KB

Validation of the SCM-test for the diagn

Validation of the SCM-test for the diagnosis of cancer

✍ Deutsch, M.; Weinreb, A. 📂 Article 📅 1983 🏛 Elsevier Science ⚖ 656 KB

Tumour specificity of the SCM test for c

Tumour specificity of the SCM test for cancer diagnosis

✍ Weinreb, A.; Chaitchik, S.; Asher, O.; Deutsch, M. 📂 Article 📅 1985 🏛 Elsevier Science ⚖ 581 KB

An analysis of the scm test in cancer di

An analysis of the scm test in cancer diagnosis

✍ R. J. Atkinson; W. S. Lowry; Patricia Strain 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB

A new diagnostic blood test for cancer, the Structuredness of Cytoplasmic Matrix (SCM) test, has been widely claimed to distinguish between normal healthy controls and patients with malignant disease. It has also been claimed that the test distinguishes between patients with nonmalignant conditions